Brief: Medicinova Announces Mn-166 (Ibudilast) Als Abstract Accepted For Presentation At The 32Nd International Symposium On Als/Mnd
30/08/2021 12:35
Aug 30 (Reuters) - MediciNova Inc MNOV.O :
* MEDICINOVA ANNOUNCES MN-166 (IBUDILAST) ALS ABSTRACT
ACCEPTED
FOR PRESENTATION AT THE 32ND INTERNATIONAL SYMPOSIUM ON ALS/MND
Source text for Eikon: ID:nGNX7p40MS
Further company coverage: MNOV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicinova
See all newsBrief: 3D Investment Partners Cuts Stake In Medicinova To 9.88% From 11.22%, Filing Shows
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX
MediciNova falls as fatty liver drug misses significance on blood-fat reduction
US STOCKS ON THE MOVE-WhiteHawk, Nvidia, Snowflake